mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0007 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.08 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.3 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.07 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |